Pharmacoeconomics and Outcomes Research Unit, Department of Clinical Pharmacy, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia.
Saudi Pharm J. 2013 Oct;21(4):361-70. doi: 10.1016/j.jsps.2012.12.006.
The purpose of this national survey is to evaluate hospital pharmacy practice in the Riyadh region of Saudi Arabia. The results of the survey pertaining to the monitoring and patient education of the medication use process were presented.
We have invited pharmacy directors from all 48 hospitals in the Riyadh region to participate in a modified-American Society of Health-System Pharmacists (ASHP) survey questionnaire. The survey was conducted using similar methods to those of the ASHP surveys.
The response rate was 60.4% (29/48). Most hospitals (23, 79%) had pharmacists regularly monitor medication therapy for patients. Of these hospitals, 61% had pharmacists monitoring medication therapy daily for less than 26% of patients, 17% monitored 26-50% of patients and 22% monitored more than half of patients daily. In 41% of hospitals, pharmacists routinely monitored serum medication concentrations or their surrogate markers; 27% gave pharmacists the authority to order initial serum medication concentrations, and 40% allowed pharmacists to adjust dosages. Pharmacists routinely documented their medication therapy monitoring activities in 52% of hospitals. Overall, 74% of hospitals had an adverse drug event (ADE) reporting system, 59% had a multidisciplinary committee responsible for reviewing ADEs, and 63% had a medication safety committee. Complete electronic medical record (EMR) systems were available in 15% of hospitals and 81% had a partial EMR system. The primary responsibility for performing patient medication education lays with nursing (37%), pharmacy (37%), or was a shared responsibility (26%). In 44% of hospitals, pharmacists provided medication education to half or more inpatients and in a third of hospitals, pharmacists gave medication education to 26% or more of patients at discharge.
Hospital pharmacists in the Riyadh region are actively engaged in monitoring medication therapy and providing patient medication education, although there is considerable opportunity for further involvement.
本项全国性调查旨在评估沙特阿拉伯利雅得地区的医院药学实践。本调查呈现了与用药过程监测和患者教育相关的结果。
我们邀请了利雅得地区所有 48 家医院的药剂科主任参与一项经过修改的美国卫生系统药师协会(ASHP)调查问卷调查。该调查采用与 ASHP 调查类似的方法进行。
回复率为 60.4%(29/48)。大多数医院(23 家,79%)有药师定期监测患者的药物治疗情况。在这些医院中,61%的药师每天监测不到 26%的患者的药物治疗情况,17%的药师每天监测 26-50%的患者,22%的药师每天监测超过一半的患者。41%的医院常规监测血清药物浓度或其替代标志物;27%的医院赋予药师开具初始血清药物浓度检测医嘱的权力,40%的医院允许药师调整剂量。52%的医院药师常规记录其药物治疗监测活动。总体而言,74%的医院有不良药物事件(ADE)报告系统,59%的医院有负责审查 ADE 的多学科委员会,63%的医院有药物安全委员会。15%的医院有完整的电子病历(EMR)系统,81%的医院有部分 EMR 系统。执行患者用药教育的主要责任落在护理(37%)、药剂科(37%)或共同承担(26%)。在 44%的医院,药师向一半或更多住院患者提供用药教育,在三分之一的医院,药师向 26%或更多出院患者提供用药教育。
利雅得地区的医院药师积极参与药物治疗监测和患者用药教育,尽管有进一步参与的机会。